Isabelle Marcoux, présidente exécutive du conseil de TC Transcontinental, honorée en tant que Fellow 2024 de l’Institut des administrateurs de sociétés (IAS)
06 juin 2024 10h30 HE
|
Transcontinental inc.
MONTRÉAL, 06 juin 2024 (GLOBE NEWSWIRE) -- Transcontinental inc. (TSX : TCL.A TCL.B) est fière de souligner le Prix Fellow 2024 de l’Institut des administrateurs de sociétés (IAS) décerné à...
Nano Dimension Announces Q1/2024 Results Demonstrating Continued Gross Margin Expansion and Path to Profitability
03 juin 2024 08h43 HE
|
Nano Dimension Ltd.
Gross Margin Improvement of 235 bps46.2% in Q1/2024, Up From 43.9% in Q1/2023Adjusted Gross Margin Improvement of 265 bps49.8% in Q1/2024, Up From 47.1% in Q1/2023 “Reshaping Nano Initiative” Taking...
Unaudited interim results for the three-month period ended 31 March 2024
30 mai 2024 02h00 HE
|
Serabi Gold plc
Unaudited interim results for the three-month period ended 31 March 2024 Serabi (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to release...
FY24 Full Year Results, Delivering on Commitments
30 mai 2024 02h00 HE
|
Renewi PLC
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 (“MAR”), AND MAR WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT...
GDEV announces preliminary unaudited results for the first quarter 2024
28 mai 2024 16h00 HE
|
GDEV Inc.
GDEV announces preliminary unaudited results for the first quarter 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integral Ad Science Holding Corp. - IAS
28 mai 2024 15h46 HE
|
Pomerantz LLP
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS). Such investors...
Evaxion Announces Business Update and First Quarter 2024 Financial Results
28 mai 2024 08h21 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, May 28, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™...
ICG: Final Results for the financial year ended 31 March 2024
28 mai 2024 02h00 HE
|
Intermediate Capital Group plc
Delivering multiple levers of growth Highlights AUM of $98bn1; fee-earning AUM of $70bn, up 11%2 compared to FY23 and five-year annualised growth of 17%2Fundraising of $13.0bn, including 31%...
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
23 mai 2024 08h00 HE
|
Trinity Biotech plc
-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million by Q2 2025- -Strong sequential 39% Q/Q growth...
Korjaustiedote: Finanssivalvonta on hyväksynyt Cargotecin osittaisjakautumista ja Kalmarin listautumista koskevan esitteen
23 mai 2024 06h30 HE
|
Cargotec Oyj
CARGOTEC OYJ, PÖRSSITIEDOTE, 23.5.2024 KLO 13.30 Korjaustiedote: Finanssivalvonta on hyväksynyt Cargotecin osittaisjakautumista ja Kalmarin listautumista koskevan esitteen Cargotec Oyj...